Top Abstract Purchase Related
Home
>
Node
>
Subnode

Structure-activity relationship analysis

Hayakawa, Y.

Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(4): 526-528

2004

ISSN/ISBN: 0385-0684
PMID: 15114695
Document Number: 572491
All samples for anticancer drug screening were classified according to their structural features and their structure-activity relationships were analyzed. Synthetic gymnastatin analogs including JCI: 11788 and JCI: 11786 altered their selectivity for protein kinase inhibition with the length of a fatty acid chain. Although a new inhibitor of tubulin depolymerization, JCI: 11578, displayed a high correlation to known tubulin binders, novel inhibitors of tubulin polymerization, JCI: 11534, JCI: 11675 and JCI: 11676, exhibited poor correlations to tubulin binders. JCI: 11403 and JCI: 11407 inhibited topoisomerase I selectively and appear to belong to a new family of topoisomerase inhibitors. They are expected to be important key compounds for structure-activity relationship analysis as well as new lead compounds for anticancer drugs.

Document emailed within 1 workday
Secure & encrypted payments

Kühmstedt, H. 1989: Computer-assisted structure-activity relationship analysis Die Pharmazie 44(6): 371-372
Tylińska, B.; Jasztold-Howorko, R.; Mastalarz, H.; Kłopotowska, D.; Filip, B.; Wietrzyk, J. 2010: Synthesis and structure-activity relationship analysis of new olivacine derivatives Acta Poloniae Pharmaceutica 67(5): 495-502
Kuz'min, V.E.; Lozitsky, V.P.; Kamalov, G.L.; Lozitskaya, R.N.; Zheltvay, A.I.; Fedtchouk, A.S.; Kryzhanovsky, D.N. 2000: Analysis of the structure-anticancer activity relationship in a set of Schiff bases of macrocyclic 2,6-bis(2- and 4-formylaryloxymethyl)pyridines Acta Biochimica Polonica 47(3): 867-875
Mokrosz, J.L.; Dukat, M.; Misztal, S.; Chojnacka-Wójcik, E.; Tatarczyńska, E. 1990: Structure-activity relationship studies of CNS agents. Part 1: the Free-Wilson analysis of acute toxicity and sedative effect of some 1,2,3,4-tetrahydro-beta-carbolines Die Pharmazie 45(10): 765-767
Mrozek, A.; Karolak-Wojciechowska, J.; Amiel, P.; Barbe, J. 2000: Quantitative analysis of structure-activity relationship in the acridine series. Part 2: Antitumor 9-thiadiazolo-acridine derivatives Acta Poloniae Pharmaceutica 57(6): 425-430
Huang, N.; Chu, F.; Guo, Z. 1998: Studies on the structure-activity relationship of retinoids--Hansch analysis and 3D-OSAR studies on specific ligands of retinoid x receptor Yao Xue Xue Bao 33(6): 442-448
Stürzebecher, J.; Markwardt, F.; Wagner, G.; Walsmann, P. 1976: Synthetic inhibitors of serine proteinases. 13. Quantitative structure-activity relationship for inhibition of trypsin and thrombin by 4-amidinophenyl compounds with a ketone structure Acta Biologica et Medica Germanica 35(12): 1665-1676
Kertscher, H.P. 1997: PAF-antagonists with lipid structure. 6. Alkylpropandiol lipids with acyl- and ether- structures at the C-3 position and heterocyclic head groups; synthesis, characterization and structure-activity relationship Die Pharmazie 52(9): 672-675
Pal'chykovs'ka, L.H.; Aleksieieva, I.V.; Kostina, V.H.; Platonov, M.O.; Nehruts'ka, V.V.; Deriabin, O.M.; Tarasov, O.A.; Shved, A.D. 2008: New amides of phenazine-1-carboxylic acid: antimicrobial activity and structure-activity relationship Ukrains'kyi Biokhimichnyi Zhurnal 80(3): 140-147
Dong, B.; Ma, T.; Zhang, T.; Zhou, C.-M.; Liu, G.; Wang, L.; Tao, P.-Z.; Zhang, X.-Q. 2011: Anti-HIV-1 activity and structure-activity relationship of pyranocoumarin analogs Yao Xue Xue Bao 46(1): 35-38
Vereczkey, L. 1995: Structure activity relationship in toxicology Acta Physiologica Hungarica 83(1): 47-50
Ciuffo, G.M.; Estrada, M.R.; Jáuregui, E.A. 1988: Structure-activity relationship in GABA receptors Acta Cientifica Venezolana 39(2): 160-165
Su, Y.Z.; Pan, Q.C.; Sun, M.Z.; Ren, Y.F. 1983: Structure-activity relationship of hexamethylmelamine derivatives Zhongguo Yao Li Xue Bao 4(4): 276-280
Tronchet, J.M. 1973: Relationship between chemical structure and pharmacodynamic activity Pharmaceutica Acta Helvetiae 48(8): 482-488
Tornetta, B.; Guerrera, F.; Mazzarino, C. 1973: Relationship between the structure and antibacterial activity of aryl-thionamides. VI. Synthesis and in vitro tuberculostatic activity of 2-alkylthio-benzothiamides and 2-alkylthio-phenyl-vinylethionamides Bollettino Chimico Farmaceutico 112(12): 832-838
Kurihara, T.; Mine, H.; Satoh, Y.; Wakabayashi, H.; Motohashi, N.; Sakagami, H. 2006: Relationship between electronic structure and cytotoxic activity of tropolones In Vivo 20(3): 391-395
Noack, E. 1984: Investigation on structure-activity relationship in organic nitrates Methods and Findings in Experimental and Clinical Pharmacology 6(10): 583-586
Kovács, G.; Székely, I.; Stadler, I.; Körmöczy, P. 1984: Structure-activity relationship (SAR) among prostacyclin (PGI2) analogues Acta Physiologica Hungarica 64(3-4): 225-230
Benigni, R. 2004: Chemical structure of mutagens and carcinogens and the relationship with biological activity Journal of Experimental and Clinical Cancer Research: Cr 23(1): 5-8
Kurihara, T.; Satoh, R.; Miyagawa, T.; Wakabayashi, H.; Motohashi, N.; Sakagami, H. 2007: Relationship between electronic structure and cytotoxic activity of azulenequinones and trihaloacetylazulenes In Vivo 21(5): 715-720